These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33831364)

  • 1. Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH.
    Ramos DM; Skarnes WC; Singleton AB; Cookson MR; Ward ME
    Neuron; 2021 Apr; 109(7):1080-1083. PubMed ID: 33831364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods of Generation of Induced Pluripotent Stem Cells and Their Application for the Therapy of Central Nervous System Diseases.
    Cherkashova EA; Leonov GE; Namestnikova DD; Solov'eva AA; Gubskii IL; Bukharova TB; Gubskii LV; Goldstein DV; Yarygin KN
    Bull Exp Biol Med; 2020 Feb; 168(4):566-573. PubMed ID: 32157511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing neural stem cell-based treatments for neurodegenerative diseases.
    Byrne JA
    Stem Cell Res Ther; 2014 May; 5(3):72. PubMed ID: 25157920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing diversity to study Alzheimer's disease: A new iPSC resource from the NIH CARD and ADNI.
    Screven LA; Pantazis CB; Andersh KM; Hong S; Vitale D; Lara E; Ku RY; Heutink P; Meyer J; Faber K; Nho K; Saykin AJ; Foroud TM; Nalls MA; Blauwendraat C; Singleton A; Narayan PS
    Neuron; 2024 Mar; 112(5):694-697. PubMed ID: 38387456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery.
    Xie YZ; Zhang RX
    Neurol Sci; 2015 Jan; 36(1):21-7. PubMed ID: 25354658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic stem cell therapies for neurodegenerative diseases.
    Tomaskovic-Crook E; Crook JM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.
    Yamashita T; Abe K
    Cell Transplant; 2014; 23(4-5):435-9. PubMed ID: 24621988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Technology for (Epi)genetic Brain Disorders.
    Riemens RJM; Soares ES; Esteller M; Delgado-Morales R
    Adv Exp Med Biol; 2017; 978():443-475. PubMed ID: 28523560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
    Haenseler W; Rajendran L
    Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease.
    Chan HJ; Yanshree ; Roy J; Tipoe GL; Fung ML; Lim LW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
    Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapies for Neurodegenerative Diseases.
    Sugaya K; Vaidya M
    Adv Exp Med Biol; 2018; 1056():61-84. PubMed ID: 29754175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
    Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell technology for neurodegenerative diseases.
    Lunn JS; Sakowski SA; Hur J; Feldman EL
    Ann Neurol; 2011 Sep; 70(3):353-61. PubMed ID: 21905078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells.
    Korecka JA; Levy S; Isacson O
    Mol Cell Neurosci; 2016 Jun; 73():3-12. PubMed ID: 26691153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.